Another $18M down the tube!! Good work! wow, not only did they pay Kedrion to take Ryplazim but they didn't get rid of this obligation. Just a well managed and oiled machine. Pritchard has taken millions here and delivered nothing. Part of well executed plan to shut this down. No experience creating any value and overpaid as heck for simply giving stuff away. Very interesting that fibrosis drug 4050 was tanked so quick and a "new, improved" fibrosis drug is being considered. This thing get shut down by Christmas
Liminal BioSciences will pay a total of $18 million, of which $11.2 million was paid upon execution of the Termination Agreement and covers past sums due to the date of termination. The Company will make two further payments of which $3.4 million will be payable in the first quarter of 2023 and the remaining $3.4 million will be payable in the first quarter of 2024. T